Skip to main content
DOCHealthpeak Properties, Inc.Sell5.0·$20.78+1.37%
Open full analysis

Healthpeak Properties, Inc. (DOC) Stock Analysis

Breakout setup

SellModerate Confidence

Real Estate · REIT - Healthcare Facilities

Sell if holding. Analyst target reached at $20.78 — A.R:R is negative (-1.0) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco lab portfolio (59.0%).

Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured... Read more

$20.78-1.4% A.UpsideScore 5.0/10#10 of 13 REIT - Healthcare Facilities
QualityF-score8 / 9FCF yield7.78%
IncomeYield5.90%(5y avg 5.57%)Payout381.26%
Stop $19.69Target $20.40(resistance)A.R:R -1.0:1
Analyst target$21.06+1.3%18 analysts
$20.40our TP
$20.78price
$21.06mean
$17
$29

Sell if holding. Analyst target reached at $20.78 — A.R:R is negative (-1.0) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco lab portfolio (59.0%). Chart setup: Golden cross, above all MAs, RSI 62, MACD bullish. Score 5.0/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 39d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-14
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Jul 23, 202639d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Geographic: San Francisco lab portfolio (59.0%)
Analyst target reached - limited upside remaining
Near 52-week high (0.6% away)

Key Metrics

P/E (TTM)64.7
P/E (Fwd)137.9
Mkt Cap$14.3B
EV/EBITDA16.2
Profit Mgn7.7%
ROE2.8%
Rev Growth7.1%
Beta1.03
Dividend5.90%
Rating analysts23

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.78neutral
IV117%elevated

Concentration Risks(10-K Item 1A)

  • LOWTenantHCA Healthcare7.0%
    10-K Item 1: 'most significant outpatient medical tenant concentration ... HCA Healthcare, Inc. (HCA)| | 15 | %| | 7 | %'
  • HIGHGeographicSan Francisco lab portfolio59%
    10-K Item 1: 'including San Francisco, California (59%), Boston, Massachusetts (22%), and San Diego, California (17%) (based on total square feet)'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.1
Support Resistance
0.7
52w Position
9.9
GatesA.R:R -1.0=NEGATIVEMomentum 6.3>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 39d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
62 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $18.90Resistance $20.82

Price Targets

$20
$20
A.Upside-1.8%
A.R:R-1.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-8.4% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-07-23 (39d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is DOC stock a buy right now?

Sell if holding. Analyst target reached at $20.78 — A.R:R is negative (-1.0) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Geographic: San Francisco lab portfolio (59.0%). Chart setup: Golden cross, above all MAs, RSI 62, MACD bullish. Prior stop was $19.69. Score 5.0/10, moderate confidence.

What is the DOC stock price target?

Take-profit target: $20.40 (-1.4% upside). Prior stop was $19.69. Stop-loss: $19.69.

What are the risks of investing in DOC?

Concentration risk — Geographic: San Francisco lab portfolio (59.0%); Analyst target reached - limited upside remaining; Near 52-week high (0.6% away).

Is DOC overvalued or undervalued?

Healthpeak Properties, Inc. trades at a P/E of 64.7 (forward 137.9). TrendMatrix value score: 4.7/10. Verdict: Sell.

What do analysts say about DOC?

23 analysts cover DOC with a consensus score of 3.7/5. Average price target: $21.

What does Healthpeak Properties, Inc. do?Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145...

Healthpeak Properties is a healthcare REIT owning 689 properties across outpatient medical (507 buildings), lab (145 buildings), and senior housing (34 communities) segments in the U.S. Revenue comes from leases to healthcare providers, biotech tenants, and RIDEA-structured senior housing operators; 2025 Adjusted NOI: outpatient medical $796M, lab $567M, senior housing $177M.

Related stocks: OHI (Omega Healthcare Investors, Inc) · SBRA (Sabra Health Care REIT, Inc.) · AHR (American Healthcare REIT, Inc.) · SILA (Sila Realty Trust, Inc.) · MPT (Medical Properties Trust, Inc.)
Home Stocks DOC

Latest news

Latest News

GuruFocus48d agoAnalyst
MarketBeat48d ago
MarketBeat48d agoAnalyst
Seeking Alpha41d ago
MarketWatch46d ago
The Motley Fool46d ago
MarketBeat43d ago
MarketBeat51d agoAnalyst
MarketBeat44d ago
MarketBeat44d ago
MarketBeat45d agoAnalyst
MarketBeat50d ago
TradingView42d agoEarnings
Benzinga4d ago
Benzinga14d agoAnalyst
Benzinga19d agoAnalyst
Benzinga24d agoAnalyst
Benzinga32d ago
Benzinga33d agoAnalyst
Benzinga33d ago
Loading more...